Treatment compliance in patients with comorbid psychiatric and substance use disorders

被引:39
|
作者
Herbeck, DM
Fitek, DJ
Svikis, DS
Montoya, ID
Marcus, SC
West, JC
机构
[1] Univ Calif Los Angeles, Integrated Subst Abuse Programs, Los Angeles, CA 90025 USA
[2] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA
[3] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA
[4] NIDA, Div Treatment Res & Dev, Bethesda, MD 20892 USA
[5] Univ Penn, Sch Social Work, Philadelphia, PA 19104 USA
[6] Amer Psychiat Inst Res & Educ, Practice Res Network, Washington, DC USA
来源
AMERICAN JOURNAL ON ADDICTIONS | 2005年 / 14卷 / 03期
关键词
D O I
10.1080/10550490590949488
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
This study examines clinical and non-clinical factors associated with treatment compliance problems in 342 patients with substance use disorders (SUD) seen in routine psychiatric practice. Weighted Wald-X-2 and multivariate logistic regression assessed sociodemographic, clinical, treatment, and health plan characteristics associated with treatment compliance problems. Among patients with SUD, 40.5% were reported to currently have treatment compliance problems. Patients with treatment compliance problems were significantly more likely to have personality disorders, lower global assessment of functioning scores, and medication side effects than those without treatment compliance problems. Patients seen by psychiatrists who were reimbursed by discounted rather than undiscounted fee-for-service were five times more likely to be reported to have treatment compliance problems. Both clinical and non-clinical factors appear to be associated with treatment compliance problems. Understanding these factors and targeting treatment interventions may improve treatment compliance and patient outcomes.
引用
收藏
页码:195 / 207
页数:13
相关论文
共 50 条
  • [1] Treatment of substance abusing patients with comorbid psychiatric disorders
    Kelly, Thomas M.
    Daley, Dennis C.
    Douaihy, Antoine B.
    [J]. ADDICTIVE BEHAVIORS, 2012, 37 (01) : 11 - 24
  • [2] Treatment of Comorbid Tobacco Addiction in Substance Use and Psychiatric Disorders
    Ouellet-Plamondon C.
    Mohamed N.S.
    Sharif-Razi M.
    Simpkin E.
    George T.P.
    [J]. Current Addiction Reports, 2014, 1 (1) : 61 - 68
  • [3] Effective Psychosocial Treatment for Patients with Substance Use Disorders and Comorbid Psychiatric Disorders: A Mission Impossible?
    Moggi, F.
    [J]. SUCHTTHERAPIE, 2014, 15 (01) : 9 - 15
  • [4] Psychiatric care of patients with depression and comorbid substance use disorders
    Montoya, ID
    Svikis, D
    Marcus, SC
    Suarez, A
    Tanielian, T
    Pincus, HA
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (09) : 698 - 705
  • [5] Comparisons of patients with comorbid psychiatric and substance use disorders: Implications for treatment and service delivery
    Havassy, BE
    Alvidrez, J
    Owen, KK
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (01): : 139 - 145
  • [6] Comorbid psychiatric disorders in chronic pain patients with psychoactive substance use disorders
    Fishbain, DA
    Cutler, RB
    Rosomoff, HL
    Rosomoff, RS
    [J]. PAIN CLINIC, 1998, 11 (02): : 79 - 87
  • [7] Treatment of patients with schizophrenia and comorbid substance use disorders
    Dilbaz, Nesrin
    Darcin, Asli Enez
    [J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 21 (01): : 80 - 90
  • [8] Prevalence and Impact of Medical Disorders in Hospitalized Psychiatric Patients with Comorbid Substance Use Disorders
    Ceilley, John
    Douaihy, Antoine
    Salloum, Ihsan
    [J]. ADDICTIVE DISORDERS & THEIR TREATMENT, 2005, 4 (02): : 65 - 70
  • [9] Current Challenges With Comorbid Psychiatric and Substance Use Disorders
    Crockford, David
    [J]. CANADIAN JOURNAL OF ADDICTION, 2021, 12 (03) : 4 - 6
  • [10] Epidemiology of comorbid substance use and psychiatric disorders in Asia
    Thirthalli, Jagadisha
    Kumar, Channaveerachari Naveen
    Arunachal, Gautham
    [J]. CURRENT OPINION IN PSYCHIATRY, 2012, 25 (03) : 172 - 180